ArticleFrontiers in cellular and infection microbiology2026
Optimising perioperative antimicrobial stewardship for Class I incisions: a clinical pharmacist-led multidisciplinary intervention and outcomes.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Aerobic and Facultative Bacterial Spectrum and Antimicrobial Susceptibility Patterns in Pediatric Acute Appendicitis: A Prospective Local Surveillance Study.International journal of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Appropriate prophylactic antimicrobial use in Class I (clean) incision surgery is crucial for patient safety and combating resistance. Although guidelines discourage routine prophylaxis, overuse remains prevalent. This study evaluated the effectiveness of a clinical pharmacist-led, multimodal antimicrobial stewardship programme (ASP) in optimising perioperative antimicrobial use for Class I incision surgeries. Methods: A single-centre, quasi-experimental study with a historical control design was conducted. Consecutive patients undergoing Class I incision surgery were included in pre-intervention (September 2024-February 2025) and post-intervention (March 2025-August 2025) groups. The intervention comprised four components: (1) formation of a multidisciplinary ASP team led by clinical pharmacists, (2) embedding pharmacists within surgical departments for real-time stewardship, (3) implementation of standardised training and protocols, and (4) deployment of an informatised monitoring and performance feedback system. Primary outcomes were prophylactic antimicrobial use rate, appropriate drug selection rate, and average duration of prophylaxis. Secondary outcomes included appropriate timing and duration rates, surgical site infection (SSI) rate, antimicrobial cost, length of stay, and adverse drug reactions. Results: A total of 824 patients in the pre-intervention group and 997 patients in the post-intervention group were included. Prophylactic antimicrobial use decreased significantly from 51.21% to 30.79% (P<0.001). Appropriate drug selection improved from 88.74% to 96.96% (P<0.001), and average prophylaxis duration decreased from 3.0 to 1.2 days (P<0.001). The SSI rate remained stable (0.97% vs. 0.70%, P = 0.623). Significant improvements were observed in appropriate timing (94.60% to 99.70%, P<0.001) and duration rates (96.41% to 98.19%, P = 0.042), along with reductions in per capita antimicrobial cost (320 RMB to 150 RMB, P<0.001), length of stay (2.5 days to 1.8 days, P<0.001), and antimicrobial-related adverse reactions (1.09% to 0.40%, P = 0.037). Conclusion: A clinical pharmacist-led multimodal ASP intervention significantly improved the appropriate use of perioperative antimicrobial prophylaxis for Class I incision surgeries, reducing unnecessary use and costs without increasing SSI risk. This approach represents an effective and replicable stewardship model for routine surgical care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.